By Dr Jia (Jenny) Liu

Conference Abstracts

Parmar J; Aggarwal N; Zdanska O; Yousif J; Hurwitz J; Handel E; Rodrigues A; Prawira A; Joshua A; Cosman R; Liu J, 2022, 'Telehealth maintains access to early phase clinical trials during the Covid-19 pandemic', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 154 - 155

Liu JJ; Zhang M; Rose B; Veillard A-S; Jones D; Lee S; Hong A, 2014, 'KI67 EXPRESSION HAS PROGNOSTIC SIGNIFICANCE IN RELATION TO HUMAN PAPILLOMAVIRUS STATUS IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 10, pp. 180 - 181, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900317&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu J; Hesson LB; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Abstract 3125: Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', in Cancer Research, American Association for Cancer Research (AACR), Vol. 72, pp. 3125 - 3125, http://dx.doi.org/10.1158/1538-7445.am2012-3125

Preprints

Smith B; Wu VS; Pearce A; Liu J; Shepherd HL; Shaw J; Girgis A; Garvey G; Kirsten L; Zakhary I; Ee C; Ewald D; Miller A; Smith A; Virk AK; Gao J; Taylor N, Designing for Delivery: A Delphi Study of Feasibility-Informed Implementation Strategies for a Fear of Cancer Recurrence Clinical Pathway, http://dx.doi.org/10.21203/rs.3.rs-8889572/v1

Wu VS; Crawford-Williams F; Cook O; Liu J; Ftanou M; Philp S; Taylor N; David M; Zakhary I; Tutton L; Smith B, Development and evaluation of an online training module for health professionals to address fear of cancer recurrence in clinical practice, http://dx.doi.org/10.21203/rs.3.rs-10491620/v1

Cai Z; Boys EL; Noor Z; Aref A; Xavier D; Lucas N; Williams SG; Koh JMS; Poulos RC; Wu Y; Dausmann M; MacKenzie KL; Aguilar-Mahecha A; Armengol C; Barranco MM; Basik M; Bowman ED; Clifton-Bligh RJ; Connolly EA; Cooper WA; Dalal B; DeFazio A; Filipits M; Flynn PJ; Graham JD; George J; Gill AJ; Gnant M; Habib R; Harris CC; Harvey K; Horvath LG; Jackson C; Kohonen-Corish MRJ; Lim E; Liu J; Long G; Lord RV; Mann GJ; McCaughan GW; Morgan L; Murphy LC; Nagabushan S; Nagrial AM; Navinés J; Panizza BJ; Samra JS; Scolyer RA; Souglakos I; Swarbrick A; Thomas DM; Balleine RL; Hains PG; Robinson PJ; Zhong Q; Reddel RR, Federated deep learning enables cancer subtyping by proteomics, http://dx.doi.org/10.1101/2024.10.16.618763

Serafimovska A; Liu J; Beith J; Butow P, Patients’ and Oncologists’ Perspectives On A Novel Clinician Led Fear of Cancer Recurrence (CIFeR) Intervention, http://dx.doi.org/10.21203/rs.3.rs-340166/v1

Smith AB; Girgis A; Taylor N; Pearce A; Liu J; Shepherd HL; Wu VS; Garvey G; Kirsten L; Zakhary I; Ee C; Ewald D; Miller A; Shaw J, Step-by-step: A clinical pathway for stepped care management of fear of cancer recurrence– results of a three round online Delphi consensus process with Australian health professionals and researchers, http://dx.doi.org/10.21203/rs.3.rs-4373417/v1

Other

Liu J; Farrow M; Hsing SS; Cosman R; Lemech CR; Teng C; Pal A; Nindra U; Parsonson AO; Park JJW; Rodrigues A; Chan WY; Wei J; Cohen J; Underhill CR; Brungs D; Hui M; Nagrial A; Jain S; Joshua AM, 2026, Data from Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance, http://dx.doi.org/10.1158/1078-0432.c.8715322

Liu J; Farrow M; Hsing SS; Cosman R; Lemech CR; Teng C; Pal A; Nindra U; Parsonson AO; Park JJW; Rodrigues A; Chan WY; Wei J; Cohen J; Underhill CR; Brungs D; Hui M; Nagrial A; Jain S; Joshua AM, 2026, Supplementary Data 1 from Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance, http://dx.doi.org/10.1158/1078-0432.33775921

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.c.7761697

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051228

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051225

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051222

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051219

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051216

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051213

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051210

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051207

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051204

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760596

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760593

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760590

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760587

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760584

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure 6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760581

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760578

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760575

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760572

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760569

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760566

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760563

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760560

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760557

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Table 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760554

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Table 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760551

Jackson CC; Liu JJ; Liu HY; Williams SG; Anees A; Noor Z; Lucas N; Xavier D; Hains PG; Bucio-Noble D; Aref AT; Porceddu SV; Ladwa R; Whitfield J; Reddel RR; Zhong Q; Panizza BJ; Robinson PJ, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760548

Back to profile page